Website Disclaimer (Pharmaceutical Information)
Important information about the nature and use of this website.
Last updated: 11 June 2026 | www.lexigenhealthcare.com
This page may be published as a standalone footer page or merged into the Terms of Use. It addresses the specific risks of a pharmaceutical trading business operating a public website.
1. Business-to-business audience
This Site is intended solely for pharmaceutical industry professionals, licensed wholesalers, distributors, healthcare institutions and prospective commercial partners. It is not intended for patients or members of the public.
2. No promotion or supply of medicines to the public
Lexigen does not sell or supply medicinal products to the public, and nothing on this Site constitutes the advertising or promotion of prescription-only or other medicinal products to the public in the UAE, the UK, the EU, Hong Kong, mainland China or any other jurisdiction. Any product references are for corporate and business-development information only.
3. No medical advice
Content on this Site is not medical advice and must not be used as a substitute for consultation with a qualified healthcare professional. If you have questions about a medicine, consult your doctor or pharmacist. Always read product labels and patient information leaflets.
4. Regulatory status
Products referred to on this Site may not be licensed or available in all countries, and may be subject to different regulatory classifications, indications or labelling in different markets. Supply is always subject to the laws, licences and marketing authorisations applicable in the relevant jurisdiction.
5. Adverse events
This Site is not a channel for reporting adverse events or product quality complaints. Suspected adverse events should be reported to the relevant marketing authorisation holder or national competent authority (e.g. the MHRA Yellow Card scheme in the UK).
6. Forward-looking statements
Statements about Lexigen's plans, pipeline or market opportunities are forward-looking, involve uncertainty, and should not be relied upon as guarantees of future performance.